Immunoassay Market Size to Grow at a CAGR of more than 9%: the industry to witness positive impact due to COVID-19 spread

As per the study initiated by Evolve Business Intelligence, the global Immunoassay market size is expected to grow at a CAGR of more than 9% from 2021 to 2028.

Get Free Exclusive Sample PDF of the report: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=005610

COVID-19 scenario:
• The temporary lockdown and restriction have led to supply chain disruption, presenting import and export challenges across different sectors.
• The companies operating in the Immunoassay market have been positively impacted due to the COVID-19 pandemic resulted in an increase in the growth of the market for 2020 and 2021

The rise in number of covid cases has increased the demand for immunoassay market as diagnosis is only way to control the spread of disease. The demand for rapid test kit has increased as it is used for surveillance and also to control the spread of virus. The demand for the rapid test kit has increased across the globe due to mass scale diagnosis of covid.

The reagents & kits hold for the largest market share and is expected to grow at the highest due to the high consumption for the diagnostic purposes.

IMP NOTE: All our reports will be updated considering the impact of the COVID-19 scenario before delivery.

The global Immunoassay market provides an in-depth analysis of key players which includes:
• Danaher
• Thermo Fisher Scientific
• Abbott Laboratories
• Roche
• Siemens Healthineer
• Quidel
• DiaSorin
• BioMérieux
• Bio-Rad Laboratories
• Ortho Clinical Diagnostics

The global Immunoassay Market is segmented based on Product, Technology, Application, and end user. On the basis of product, the market is segmented as Reagents & Kits, Analyzers. Based on the technology, the market is segmented as ELISA, IFA, Rapid Tests, Radio Immunoassay. based on the specimen, the market is analyzed across the Blood, Saliva, Urine. based on the application, the market is analyzed across the Infectious Diseases, Oncology. And based on the end user, the market is analyzed across the Hospitals & Clinics.

For Any Query or Customization, Ask to Our Industry Experts@ https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=005610

Global Immunoassay Market Geographic Coverage:
Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
• Rest of the World (the Middle East & Africa and South America)

Key Questioned Answered Through The Report:
• The Impact of COVID-19 on the global market
• What are the potential opportunities for new entrants in the global market
• What is the market Size and Forecast from 2020 to 2028?
• Key Players associated with the global Immunoassay Market
• Value Chain Analysis of Global Immunoassay Market
• What is the CAGR of the global Immunoassay Market from 2021 to 2028
• Major Growth Factor, Challenges, Trends, and Opportunities in the global market
• Key outcomes of SWOT Analysis

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
NH 48, Balitha, Gujarat,
India
Contact: +1 773 644 5507 / +91 635 396 3987
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool – EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune’s global 2000 companies.

This release was published on openPR.